| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $828,523 ) |
| | 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01EY034672 | Role of Macrophages in ocular GVHD | 000 | 1 | NIH | 1/27/2023 | $342,000 |
| | 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 001 | 5 | NIH | 3/17/2023 | $6,983 |
| | 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 000 | 5 | NIH | 3/7/2023 | $342,140 |
| | 2023 | 2023 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03AI168826 | Mechanisms and In Vivo Activity of a Next Generation Daptomycin Antibiotic | 000 | 1 | NIH | 11/4/2022 | $69,000 |
| | 2023 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 000 | 4 | NIH | 3/16/2023 | $0 |
| | 2023 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R03TR004248 | A precision medicine approach to identify walking phenotypes and rehabilitation targets after injury | 001 | 2 | NIH | 12/20/2022 | $68,400 |
| | 2023 | 2021 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R33NS101182 | Development of SK channel modulators as therapeutic agents for ataxia | 000 | 3 | NIH | 12/22/2022 | $0 |
| | 2023 | 2019 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 001 | 6 | NIH | 1/4/2023 | $90,289 |
| | 2023 | 2018 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 000 | 5 | NIH | 1/4/2023 | -$90,289 |
|
| Issue Date FY: 2022 ( Subtotal = $5,270,912 ) |
| | 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01HL147311 | Cilia-specific cAMP plays a major role in aneurysm | 000 | 3 | NIH | 6/16/2022 | $345,000 |
| | 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 000 | 4 | NIH | 3/23/2022 | $287,488 |
| | 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01HD092612 | The influence of brain organization and postural behavior on progression of back pain symptoms in young adults. | 000 | 5 | NIH | 6/27/2022 | $119,135 |
| | 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 000 | 9 | NIH | 7/18/2022 | $300,426 |
| | 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 001 | 4 | NIH | 3/30/2022 | $31,943 |
| | 2022 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 001 | 3 | NIH | 8/16/2022 | $0 |
| | 2022 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG054442 | Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | 000 | 3 | NIH | 8/11/2022 | $3,199,665 |
| | 2022 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA264913 | Defining the role of plasma cells in the establishment of KSHV infection in human tonsil | 000 | 2 | NIH | 8/14/2022 | $345,000 |
| | 2022 | 2022 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 003 | 4 | NIH | 4/28/2022 | $377,708 |
| | 2022 | 2022 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 002 | 4 | NIH | 7/28/2022 | $29,808 |
| | 2022 | 2021 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 002 | 3 | NIH | 2/28/2022 | $234,733 |
| | 2022 | 2020 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 004 | 2 | NIH | 5/10/2022 | $0 |
| | 2022 | 2020 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 005 | 2 | NIH | 5/10/2022 | $0 |
| | 2022 | 2020 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 006 | 2 | NIH | 5/10/2022 | $0 |
| | 2022 | 2019 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R21NS101182 | Development of SK channel modulators as therapeutic agents for ataxia | 000 | 2 | NIH | 9/26/2022 | $6 |
| | 2022 | 2019 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R00DE024969 | Factors Influencing KSHV Infection and Spread within the Oral Cavity | 002 | 5 | NIH | 6/29/2022 | -$36 |
| | 2022 | 2019 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 002 | 6 | NIH | 9/21/2022 | -$90,283 |
| | 2022 | 2018 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R00DE024969 | Factors Influencing KSHV Infection and Spread within the Oral Cavity | 001 | 4 | NIH | 6/29/2022 | $0 |
| | 2022 | 2018 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 001 | 5 | NIH | 9/21/2022 | $90,283 |
| | 2022 | 2018 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 003 | 2 | NIH | 5/10/2022 | $0 |
| | 2022 | 2018 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 002 | 2 | NIH | 5/10/2022 | $0 |
| | 2022 | 2017 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R15CA208656 | Breast Cancer Targeting Peptides for Improved Efficacy of Current Cancer Treatment | 000 | 1 | NIH | 8/3/2022 | $0 |
| | 2022 | 2017 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 000 | 2 | NIH | 5/3/2022 | $0 |
| | 2022 | 2017 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | RF1AG054442 | Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population | 001 | 2 | NIH | 5/10/2022 | $0 |
| | 2022 | 2017 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R56HL131577 | The signaling mechanism of primary cilia in aneurysm prevention | 000 | 1 | NIH | 9/26/2022 | $36 |
| | 2022 | 2017 | CHAPMAN UNIVERSITY | 1 UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R00DE024969 | Factors Influencing KSHV Infection and Spread within the Oral Cavity | 000 | 3 | NIH | 6/29/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $3,151,307 ) (Continued on the next page) |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 002 | 3 | NIH | 9/24/2021 | $179,396 |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01AG062840 | A Brain Penetrating Bi-functional Transferrin Receptor Antibody-TNF-alpha Decoy Receptor Fusion Protein for Alzheimer's Disease | 001 | 3 | NIH | 8/12/2021 | $198,312 |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01GM107094 | Molecular signal transduction of cAMP compartments | 000 | 8 | NIH | 6/25/2021 | $300,426 |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R33NS101182 | Development of SK channel modulators as therapeutic agents for ataxia | 001 | 3 | NIH | 7/26/2021 | $6 |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R33NS101182 | Development of SK channel modulators as therapeutic agents for ataxia | 000 | 3 | NIH | 12/29/2020 | $723,140 |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01HL147311 | Cilia-specific cAMP plays a major role in aneurysm | 001 | 2 | NIH | 6/9/2021 | $375,778 |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01HL147311 | Cilia-specific cAMP plays a major role in aneurysm | 000 | 2 | NIH | 6/4/2021 | $345,000 |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | K01HD092612 | The influence of brain organization and postural behavior on progression of back pain symptoms in young adults. | 000 | 4 | NIH | 7/28/2021 | $129,632 |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA239590 | Identifying susceptibility factors for KSHV infection in human tonsil | 000 | 3 | NIH | 3/26/2021 | $319,542 |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R01CA264913 | Defining the role of plasma cells in the establishment of KSHV infection in human tonsil | 000 | 1 | NIH | 9/20/2021 | $341,200 |
| | 2021 | 2021 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R00AG055699 | Neighborhood adversity and sensitivity to stress: a study of gene x environment interactions. | 000 | 5 | NIH | 5/26/2021 | $238,917 |
| | 2021 | 2019 | CHAPMAN UNIVERSITY | ONE UNIVERSITY DR | ORANGE | CA | 92866-1005 | ORANGE | USA | R21NS101182 | Development of SK channel modulators as therapeutic agents for ataxia | 000 | 2 | NIH | 7/26/2021 | -$6 |
|
